Rate of surgery and baseline characteristics associated with surgery progression in young athletes with prearthritic hip disorders by Collis, Reid W et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
11-1-2020 
Rate of surgery and baseline characteristics associated with 
surgery progression in young athletes with prearthritic hip 
disorders 
Reid W Collis 
Andrea B McCullough 
Chris Ng 
Heidi Prather 
Graham A Colditz 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Authors 
Reid W Collis, Andrea B McCullough, Chris Ng, Heidi Prather, Graham A Colditz, John C Clohisy, and Abby 
L Cheng 
Original Research
Rate of Surgery and Baseline Characteristics
Associated With Surgery Progression in
Young Athletes With Prearthritic Hip Disorders
Reid W. Collis,* BS, Andrea B. McCullough,† MD, Chris Ng,‡ MD, MBA, Heidi Prather,§ DO,
Graham A. Colditz,k DrPH, MD, MPH, John C. Clohisy,{ MD, and Abby L. Cheng,§# MD
Investigation performed at Washington University School of Medicine, St. Louis, Missouri, USA
Background: Prearthritic hip disorders (PAHD), such as femoroacetabular impingement (FAI), acetabular dysplasia, and ace-
tabular labral tears, are a common cause of pain and dysfunction in adolescent and young adult athletes, and optimal patient-
specific treatment has not been defined. Operative management is often recommended, but conservative management may be a
reasonable approach for some athletes.
Purpose: To identify (1) the relative rate of progression to surgery in self-reported competitive athletes versus nonathletes with
PAHD and (2) baseline demographic, pain, and functional differences between athletes who proceeded versus those who did not
proceed to surgery within 1 year of evaluation.
Study Design: Cohort study; Level of evidence, 3.
Methods: An electronic medical record review was performed of middle school, high school, and college patients who were
evaluated for PAHD at a single tertiary-care academic medical center between June 22, 2015, and May 1, 2018. Extracted vari-
ables included patients’ self-reported athlete status, decision to choose surgery within 1 year of evaluation, and baseline self-
reported pain and functional scores on Patient-Reported Outcomes Measurement Information System (PROMIS) domains, the Hip
disability and Osteoarthritis Outcome Score (HOOS), and the modified Harris Hip Score.
Results: Of 260 eligible patients (289 hips), 203 patients (78%; 227 hips) were athletes. Athletes were no more likely to choose surgery
than nonathletes (130/227 hips [57%] vs 36/62 hips [58%]; relative risk [RR], 0.99 [95% CI, 0.78-1.25]). Among athletes, those who
proceeded to surgery over conservative care were more likely to be female (81% vs 69%; RR, 1.34 [95% CI, 0.98-1.83]) and had more
known imaging abnormalities (FAI: 82% vs 69%, RR, 1.47 [95% CI, 1.09-1.99]; dysplasia: 48% vs 27%, RR, 1.44 [95% CI, 1.16-1.79];
mixeddeformity: 30% vs 10%, RR, 2.91 [95%CI, 1.53-5.54]; known labral tear: 84% vs 40%, RR, 2.79 [95%CI, 2.06-3.76]). Athletes who
chose surgery also reported worse baseline hip-specific symptoms on all HOOS subscales (mean difference, 10.8-17.7; P< .01 for all).
Conclusion: Similar to nonathletes, just over half of athletes with PAHD chose surgical management within 1 year of evaluation.
Many competitive athletes with PAHD continued with conservative management and deferred surgery, but more structural hip
pathology and worse hip-related baseline physical impairment were associated with the choice to pursue surgery.
Keywords: femoroacetabular impingement; acetabular dysplasia; acetabular labral tear; athletes; hip arthroscopy; conservative
management
Prearthritic hip disorders (PAHD) are variations in hip
anatomy that can contribute to chronic pain, disability, and
early hip osteoarthritis (OA) in otherwise healthy adoles-
cents and young adults.10,33 Conditions such as femoroace-
tabular impingement (FAI), acetabular dysplasia, and
acetabular labral tears are all examples of PAHD, and
these conditions preferentially affect athletes.11,14 A recent
meta-analysis demonstrated that athletes who participate
in sports such as ice hockey, basketball, and other jumping
sports during adolescence have a 1.9- to 8-fold increased
risk of developing a cam deformity during skeletal matura-
tion.31 Labral tears are also particularly common in ath-
letes who participate in sports that involve cutting and
rotation-related movements,30 with incidence rates of
asymptomatic labral tears as high as 89% in adolescent
skiers and hockey players.5 Furthermore, a high rate of
acetabular dysplasia has been found in ballet dancers.18
The high prevalence of PAHD in athletes may contribute
to the higher prevalence of hip OA in former athletes com-
pared with nonathletes.50
Athletes diagnosed with symptomatic PAHD currently
face a dilemma when choosing a treatment path. They must
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consider both the overall efficacy of the treatment plan and
its impact on returning to sport. Surgical management is
often recommended and can result in relatively good
return-to-sport rates when performed by experienced sur-
geons. After surgery for FAI, 87% of athletes return to
sport,7 and after periacetabular osteotomy for dysplasia,
80% return to sport and only 7% to 11% report activity
limitations from persistent hip pain.4,20,37 However, the
mean time to return to sport after FAI surgery is 9.4
months,32 and the median return time after periacetabu-
lar osteotomy is 9 months.20 These prolonged recovery
times are undesirable for many athletes. Because sports
participation is associated with increased subjective well-
being13 and because injuries in athletes are known to con-
tribute to emotional distress,25,27,41,45 minimizing time
away from sport should be a consideration in the manage-
ment of PAHD.
Conservative management typically offers a quicker
return to play than surgical management,35,39 and it has
proven to be effective in some athletes.22 However, athletes
who do not improve sufficiently with an extensive trial of
conservative care and proceed to surgery anyway have an
even more protracted return to play than if they had pur-
sued surgery earlier in their course.22 To our knowledge,
the proportion of competitive athletes who pursue surgery
over continued conservative management is unknown. Fur-
thermore, identification of athlete-specific variables that
are associated with progression to surgery rather than con-
tinued conservative management may assist providers in
counseling patients and directing them to appropriate
treatment options that will expedite their recovery and
return to play.
The purpose of this study was 2-fold: (1) to identify the
relative rate of progression to surgery in self-reported com-
petitive athletes versus nonathletes with PAHD and iden-
tify unique baseline characteristics associated with being
an athlete, and (2) to identify demographic, pain, and func-
tional differences between athletes who proceed versus do
not proceed to surgery within 1 year of evaluation. We
hypothesized that the high physical demand in athletes
would result in a higher rate of surgery compared with
nonathletes and that athletes who chose surgery would
report worse baseline pain and function compared with
those who continued with conservative care.
METHODS
This retrospective cohort study was conducted at a single
tertiary-care academic medical center. Institutional review
board approval was granted by the institution.
Patients
Participants included adolescent and young adult patients
aged 13 to 25 years who were initially evaluated by a board-
certified nonoperative sports medicine specialist or ortho-
paedic surgeon with sports medicine and/or hip preservation
expertise. Patients were included regardless of whether they
had previously been evaluated by other providers at differ-
ent institutions or with different medical training for the
same issue (such as a primary care physician, physical ther-
apist, and/or athletic trainer). Patients had to report a chief
complaint of hip pain, and the physician documentation had
to state that an intra-articular, nonarthritic hip disorder was
the suspected cause of their symptoms. Eligible structural
diagnoses included cam FAI (ie, reduced femoral head-neck
offset), pincer FAI (ie, acetabular overcoverage), combined
FAI (ie, coexisting cam and pincer morphology), acetabular
dysplasia (ie, acetabular undercoverage), mixed deformity
(ie, coexisting cam FAI and acetabular dysplasia), and ace-
tabular labral tear. Both FAI and dysplasia morphology
were included in this study because the patient popula-
tions, clinical evaluations, and initial treatment recom-
mendations often overlap, and the conditions can
commonly coexist.52 Consistent with previous
effectiveness-focused research in this population,16,38 no
specific quantitative radiographic measurement cutoffs
were required for inclusion.
Because the distinction of “competitive athlete” can
become ambiguous in adult populations who participate
in activities ranging from intramural city leagues to
regional or national club leagues to professional sports, the
eligible cohort for this study was restricted to students in
middle school, high school, and college at the time of initial
evaluation. In this population, competitive athletics can be
defined in a more straightforward fashion, for example
by participation in organized youth or young adult activi-
ties such as school-sponsored sports or by participation in
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higher-level competition such as semiprofessional or pro-
fessional sports.
All initial clinical encounters occurred between June 22,
2015, and May 1, 2018. The start date was chosen to corre-
spond with implementation of Patient-Reported Outcomes
Measurement Information System (PROMIS) measure col-
lection as standard of care for all patients evaluated at our
orthopaedic department. Some of the PROMIS measures
are specifically designed for patients of certain age groups,
so for this study we defined adolescents as being 13 to 17
years old and young adults as patients 18 years and older.
Exclusion criteria included other hip conditions that tend to
initially present in a different patient demographic (eg,
slipped capital femoral epiphysis, Legg-Calvé-Perthes dis-
ease, and avascular necrosis), moderate or severe hip OA
(Tönnis grade 2 or 3), prior same-side hip surgery or frac-
ture, prior same-side hip infection or tumor, inflammatory
arthropathy, and pregnancy. Patients whose competitive
athletic status was unknown were also excluded.
Given the observational nature of this study, there was
no predetermined, strict treatment protocol for these
patients. However, all the young adult hip providers at the
study institution follow a relatively standard treatment
protocol that includes an initial trial of conservative man-
agement consisting of physical therapy, activity modifica-
tion, anti-inflammatory medications, and/or intra-articular
hip injections. Patients who do not sufficiently improve
with these conservative measures are offered surgical man-
agement if they are deemed appropriate candidates.
Potentially eligible patients were identified via a query of
hip-related billing codes (listed in the Appendix) in patients
aged between 13 and 40 years. This query was performed to
create a comprehensive repository of prearthritic hip
patients evaluated at our institution. Final eligibility for
this study was confirmed with manual chart review by 1
of 3 researchers (R.W.C., A.B.M., or C.N.). Before data
extraction, all 3 researchers underwent standardized train-
ing and assessment of appropriate, consistent data inter-
pretation. Questions regarding participant eligibility were
resolved by consultation with the senior author (A.L.C.).
Outcome Measures
The primary outcome measure was the relative rate of pro-
gression to surgery at the study institution within 1 year in
self-reported athletes versus nonathletes. (Because the
study was performed at a tertiary referral center with
regional and national recognition for expertise in hip dis-
orders in young adults, it was assumed that the vast major-
ity of patients who proceeded with surgery did so within the
study institution.) Secondary measures included compari-
son of patient characteristics and baseline self-reported
physical and behavioral health between athletes and non-
athletes and, within the athlete cohort, between those who
chose surgery versus those who did not proceed to surgery
within 1 year of evaluation.
The following self-reported descriptive variables were
recorded: patient demographics (age, sex, race, and grade
level); body mass index; baseline activity level as measured
by the University of California Los Angeles (UCLA) Activity
Score (scored from 1 [wholly inactive] to 10 [regularly active
in impact sports]); history of depression and/or low back
pain; hip pain duration; participation in competitive sports;
number of and which sports were played; and the physician-
documented PAHD diagnosis. Patients who endorsed
involvement in competitive sports were considered athletes,
while those who did not were considered nonathletes. For
the majority of patients, competitive athlete status was
determined by their answers on a standard-of-care form that
systematically inquires about their athletic participation in
organized sports. Because “being an athlete” is accompanied
by unique psychological identity traits compared with being
a person who is “physically active,”21 we felt that patients’
self-reported athlete status was the best method to capture
this construct. For the patients who were evaluated by phy-
sicians who did not routinely collect this form, athlete status
was determined by review of the clinical notes. With the
exception of the UCLA score, all descriptive variables were
recorded as part of standard clinical care for all included
patients. The UCLA score was only routinely collected in
select circumstances, as described below.
When available, baseline patient-reported outcome mea-
sures (PROMs) were also recorded (Table 1). These
included the modified Harris Hip Score (mHHS), the Hip
disability and Osteoarthritis Outcome Score (HOOS), and
physical and behavioral health domains from PROMIS.
Both the mHHS and the HOOS are hip-specific measures
that are scored from 0 to 100, with higher scores being
favorable.19,34 PROMIS consists of multiple health
domains, each of which is normalized to a mean score of
50 and standard deviation of 10 in the general population.
Higher scores represent more of the specific domain being
tested.6 PROMIS computer-adaptive test measures were
collected as part of standard clinical care. The PROMIS
Physical Function domain encompasses both upper and
lower body function, while the Mobility domain focuses
exclusively on lower body function. The Depression and
Anxiety measurements were not assessed in pediatric
patients due to concern for potential psychological distress
associated with answering the questions. The Peer Rela-
tionships domain was chosen as a proxy for pediatric psy-
chosocial health.
Of note, at this institution during the study period, the
UCLA score, mHHS, and HOOS measures were only com-
pleted as standard of care by patients who had scheduled
surgery with any hip surgeon or if they were evaluated by
the senior hip preservation surgeon (J.C.C.), regardless of
whether they pursued surgery or not. Furthermore, the
PROMIS Anxiety domain was not routinely collected until
10 months after the study start date, and the adult PRO-
MIS Mobility domain was only collected from patients who
were evaluated by surgeons. Therefore, some PROM data
were preferentially missing from patients who continued
conservative management because of the administrative
limitations of this retrospective study.
Statistical Analysis
Descriptive variables are reported as means and standard
deviations for continuous data and frequency and
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percentages for categorical data. The primary outcome was
calculated as a relative risk (RR) with a 95% CI. In patients
who were evaluated for bilateral hip pain (either at a single
encounter or over 2 separate encounters), each hip was
considered individually because progression to surgery is
specific to each hip. Additionally, a multilevel multiple
logistic regression was performed to assess the association
between athlete status and progression to surgery when
controlling for age, sex, hip morphology (ie, presence of FAI
or acetabular dysplasia), and the instances of bilateral hip
pain. Regarding the secondary measures, differences in
continuous variables (between athletes versus nonathletes
and between surgical versus nonsurgical patients among
the athlete cohort) were assessed using unpaired t tests,
and mean differences (MDs) with 95% CIs are reported.
Differences in categorical variables were evaluated using
chi-square tests or Fisher exact tests, as indicated, and the
RR with a 95% CI is reported. Because 1 primary outcome
was prespecified and the rest of the comparisons were
exploratory secondary outcomes, no multiple-comparison
adjustment was performed. Missing data are listed in the
tables shown in the Results section. P  .05 was prespeci-
fied to represent statistical significance. All statistical anal-
yses were performed using SAS software, Version 9.4.
RESULTS
Of the 1476 potential participants identified from the initial
billing query, 260 middle school, high school, and college
students (289 hips) with confirmed PAHD were eligible for
this study (Figure 1). Of these, 203 patients (78%; 227 hips)
were athletes. Running-related sports were the most com-
monly reported activity, followed closely by dance, soccer,
and baseball/softball (Table 2).
Athletes Versus Nonathletes
Athletes were no more likely than nonathletes to choose
surgery within 1 year of evaluation (130/227 hips [57%] vs
36/62 hips [58%], respectively; RR, 0.99 [95% CI 0.78-1.25];
P ¼ .91) (Table 3). Even after controlling for age, sex, pres-
ence of FAI and dysplasia, and bilateral symptoms, 2-level
multiple logistic regression did not demonstrate a statisti-
cally significantly increased surgical rate in athletes (OR,
1.20 [0.57-2.55]; P ¼ .62). However, there were other demo-
graphic differences between the 2 cohorts. Compared with
nonathletes, the athlete cohort was younger (17.1 vs 19.2
years; P < .001) and more likely to be in middle school or
high school instead of college (80% vs 33%; P < .001). The
athlete cohort also had relatively fewer female patients
(75% vs 91%; P ¼ .01), and on average, athletes were eval-
uated after a shorter symptom duration (56% vs 32% within
1 year; P < .001). Regarding hip morphology, athletes were
more likely to have a diagnosis of FAI (77% vs 56%; P ¼
.002) and were less likely to have acetabular dysplasia (39%
vs 63%; P¼ .001). The prevalence of known labral tears was
similar between groups (57% vs 58%; P ¼ .74).
Regarding self-reported physical health, athletes
reported less overall pain interference compared with
nonathletes (Adult PROMIS Pain Interference, MD ¼
2.9 points; P ¼ .017; and Pediatric PROMIS Pain Inter-
ference, MD ¼ 4.1 points, P ¼ .034), but there was no
statistically significant difference in hip-specific symp-
toms or function as measured by the mHHS or HOOS
subscales (Table 4). Adult athletes also reported better
overall physical function (Adult PROMIS Physical Func-
tion, MD ¼ –3.0 points; P ¼ .018), but lower body mobility
was not different in adolescent or adult athletes versus
nonathletes. Regarding behavioral health, athletes had a
much lower prevalence of self-reported history of depres-
sion (4% vs 28%; P < .001), but the between-group differ-
ences in Adult PROMIS Depression and Anxiety scores at
initial evaluation did not reach statistical significance. Of
note, because the majority of eligible participants were
younger than 18 years, the sample size for Adult PROMIS
measures was limited.
Progression to Surgery in Athletes
Among the athlete cohort, the surgical group was more
female predominant (81% vs 69%; P ¼ .045), had suffered
from hip pain for a somewhat longer duration (73% vs 58%
with pain longer than 6 months; P< .001), and had a higher
prevalence of radiographic FAI (82% vs 69%; P ¼ .020) and
acetabular dysplasia (48% vs 27%; P ¼ .001), especially in
TABLE 1




Pain Interference V 1.1
Physical Function V 1.2 or V 2.0
Mobility V 1.2d
Pediatric PROMIS CATb
Peer Relationships V 2.0









aADL, Activities of Daily Living; CAT, computer adaptive test;
HOOS, Hip disability and Osteoarthritis Outcome Score; mHHS,
modified Harris Hip Score; PROM, patient-reported outcome
measure; PROMIS, Patient-Reported Outcomes Measurement
Information System; QoL, Quality of Life.
bAdult PROMIS CAT measures were collected from patients
18 years of age and older. Pediatric PROMIS measures were
collected from patients younger than 18 years.
cPROMIS Anxiety was not routinely collected until 10 months
after the study start date.
dAdult PROMIS Mobility was only collected from patients
who were evaluated by surgeons.
eThe mHHS and HOOS PROMs were only completed as stan-
dard of care by patients who scheduled surgery with any hip
surgeon or if they were evaluated by the senior hip preservation
surgeon.
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the presence of a diagnosed acetabular labral tear (84% vs
40%; P< .001). Coexisting (mixed) FAI and dysplasia defor-
mity was also more common in the surgical group (30% vs
10%; P ¼ .001). Other participant demographics were sim-
ilar between those who did and did not proceed with sur-
gery (Table 5).
Compared with athletes who did not pursue surgery
within one year, athletes who progressed to surgery
reported worse hip dysfunction on all 5 HOOS subscales
(MD¼ 10.8-17.7; all P< .01) but not on the mHHS (Table 6).
Furthermore, among adolescent athletes (age <18 years),
the surgical group reported worse pain interference and
lower body mobility on PROMIS measures, as well (Pediat-
ric PROMIS Pain Interference, MD ¼ –4.7 points; P < .001;
and Pediatric PROMIS Mobility, MD ¼ 4.9 points; P <
.001). Regarding behavioral health, there was no
between-group difference in self-reported history of depres-
sion at initial evaluation. There were also no statistically
significant between-group differences on any of the Adult
PROMIS measures, but again, the sample size for this older
group of athletes was limited.
DISCUSSION
Contrary to our hypothesis, in this study of students eval-
uated with hip pain due to PAHD, athletes were no more
likely than nonathletes to choose surgical intervention
within one year of evaluation. This finding remained true
even after controlling for age, sex, presence of FAI and/or
acetabular dysplasia, and presence of bilateral hip symp-
toms. In fact, only 58% of athletes opted for surgery. Ath-
letes reported similar hip-specific symptom severity to
nonathletes, but athletes experienced less overall pain
interference and had a lower prevalence of preexisting
depression. Within the athlete cohort, longer symptom
duration, more evidence of structural abnormalities, and
worse self-reported hip symptoms and overall physical
function were associated with their choice to pursue sur-
gery. There was no definitive difference in behavioral
health between the surgical and nonsurgical groups.
Identified in billing query
N=1476
Confirmed to have PAHD 
on manual chart review
n=715 (815 hips)
Middle school, high school, and 
college students
n=297 (351 hips)












Did not pursue surgery
n=90 (97 hips)
Figure 1. Participant inclusion flowchart. PAHD, prearthritic hip disorder.
TABLE 2
Competitive Sports Participation Among Middle School,
High School, and College Students Evaluated
Between 2015 and 2018a
n (%)






Sport played (n ¼ 203)










Field hockey 5 (2)
Tennis 5 (2)
Gymnastics 5 (2)
aBecause some athletes played multiple sports, the sum of per-
centages of athletes involved in each sport exceeds 100%. Compet-
itive sports that were reported in <5 participants are not listed.
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Our results build on the findings by Hunt et al,22 in which
patients with PAHD completed a standardized conservative
management protocol and then were given the option of sur-
gical management if their symptoms were not controlled.
Similar to our results, the cohort was predominantly female,
and only 56% of those patients chose to have surgery. How-
ever, in that prospective study, patients who were more
active were more likely to choose surgery, whereas in our
cohort, competitive athletes were no more likely to proceed
to surgery than nonathletes, and the athletes who proceeded
to surgery reported similar activity levels to the athletes who
continued with conservative care. One potential reason for
the discrepancy between the two studies is that our cohort
was younger than the Hunt et al cohort (mean age, 17 vs 35
years), and younger active people are likely more involved in
organized, competitive sports during their school-aged
years, whereas older active adults may more often engage
in independent fitness activities.1,49 Our findings yield new
insights because participation in competitive sports involves
external psychosocial pressures21 often linked to injury,3,40
which makes competitive athletes a unique population dis-
tinct from generally active people. Athletes involved in com-
petitive sports have been found to have better pain coping
strategies and less pain catastrophization than
TABLE 3
Clinical Characteristics and Choice to Pursue Surgery in Athletes Versus Nonathletesa
Athletes (n ¼ 203) Nonathletes (n ¼ 57) RR (95% CI) MD (95% CI) P Value
Age, y 17.1 ± 2.2 19.2 ± 2.9 — 2.2 (1.3 to 3.0) <.001
Female sex 153 (75) 52 (91) 0.82 (0.73 to 0.92) — .010
Race .505
White 192 (95) 53 (93) 1.02 (0.94 to 1.10) —
Black 6 (3) 3 (5) 0.56 (0.14 to 2.18) —
Asian 3 (1) 0 (0) 2.00 (0.10 to 37.98) —
Hispanic/Latino 2 (1) 1 (2) 0.56 (0.05 to 6.08) —
Grade level <.001
Middle school 19 (9) 3 (5) 1.78 (0.55 to 5.80) —
High school 145 (71) 16 (28) 2.54 (1.66 to 3.89) —
College 39 (19) 38 (67) 0.29 (0.21 to 0.40) —
UCLA Activity Scoreb 7.9 ± 2.6 5.7 ± 2.7 — –2.2 (–3.1 to –1.3) <.001
BMIc 23.0 ± 3.7 23.6 ± 4.5 — 0.7 (–0.5 to 1.8) .271
Depressiond 8 (4) 15 (28) 0.14 (0.06 to 0.31) — <.001
Low back paine 28 (15) 9 (17) 0.90 (0.45 to 1.80) — .773
Athlete Hips (n ¼ 227) Nonathlete Hips (n ¼ 62)
Hip pain duration <.001
<6 mo 76 (33) 8 (13) 2.59 (1.32 to 5.08) —
6 to 12 mo 52 (23) 12 (19) 1.18 (0.68 to 2.07) —
1 to 3 y 66 (29) 18 (29) 1.00 (0.65 to 1.55) —
3 to 5 y 21 (9) 14 (23) 0.41 (0.22 to 0.76) —
>5 y 12 (5) 10 (16) 0.33 (0.15 to 0.72) —
Hip pathology —
FAI 174 (77) 35 (56) 1.36 (1.08 to 1.71) — .002
Cam 128 (56) 25 (40) 1.40 (1.01 to 1.93) —
Pincer 13 (6) 2 (3) 1.78 (0.41 to 7.66) —
Combined 6 (3) 1 (2) 1.64 (0.20 to 13.36) —
Unknown subtype 27 (12) 7 (11) 1.05 (0.48 to 2.30) —
FAI þ labral tear f 117 (52) 24 (39) 1.33 (0.95 to 1.87) — .097
Acetabular dysplasia 88 (39) 39 (63) 0.62 (0.48 to 0.79) — .001
Dysplasia þ labral tear f 56 (25) 23 (37) 0.67 (0.45 to 0.99) — .043
Mixed (FAI þ dysplasia) 49 (22) 17 (27) 0.79 (0.49 to 1.27) — .323
(Known) labral tear 148 (65) 39 (63) 1.04 (0.84 to 1.28) — .738
Chose surgery 130 (57) 36 (58) 0.99 (0.78 to 1.25) — .911
aContinuous variables are reported as mean ± SD, and categorical variables are reported as n (%). Comparisons between athletes and
nonathletes are reported as relative risk (RR) for categorical variables and mean difference (MD) for continuous variables. Boldface P values
indicate a statistically significant difference between groups. Dashes indicate not applicable. BMI, body mass index; FAI, femoroacetabular
impingement; UCLA, University of California, Los Angeles.
bAthletes, n ¼ 107; nonathletes, n ¼ 40.
cAthletes, n ¼ 202; nonathletes, n ¼ 57.
dAthletes, n ¼ 201; nonathletes, n ¼ 54.
eAthletes, n ¼ 186; nonathletes, n ¼ 54.
fPatients with FAI, dysplasia, and a known labral tear are represented in both the “FAIþ labral tear” and “Dysplasiaþ labral tear” counts.
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nonathletes,12,47 which may explain why the athletes
reported in our study reported similar levels of hip pain
severity to the nonathletes but less interference in their
daily lives from their symptoms. Furthermore, the opportu-
nity to participate in school-sponsored competitive athletics
is only possible during a limited timeframe (even in the
absence of injury), so these young competitive athletes may
be more likely than otherwise active adults to defer surgery
in order to finish a sports season or career. In contrast, active
adults may have completed their competitive careers and
have had pain for a longer duration, which may sway them
to pursue surgery if their symptoms have not adequately
been controlled with conservative measures.
Our statistically significant mean score differences
approximated or exceeded previously published minimal
clinically important differences (MCIDs) for all reported
PROMs, which are summarized in Table 7. This suggests
that the significant PROM differences in this study are
consistent with clinically meaningful findings. Of course,
comparison of our findings with previously determined
MCIDs should still be interpreted with caution because
some of the MCIDs were calculated in patients with other
medical conditions,2,8,26,28,36,48 and although the published
mHHS and HOOS MCIDs were calculated in patients with
hip pain, those patients had all undergone hip arthroscopy,
whereas many patients in our cohort did not.24
Self-reported baseline behavioral health reported by the
athletes and nonathletes in our study is also notable.
Although our athlete cohort consisted of significantly fewer
individuals with a self-reported history of depression than
the nonathlete cohort, a previous meta-analysis found
depressive symptoms to be similar in high-performance ath-
letes and nonathletes,15 and other evidence has demon-
strated a high frequency of depression in athletes after
injury.25,27,41,45 However, other literature suggests that ath-
letes may be more likely to ignore depressive symp-
toms17,42,44,51 and may be more adept at dealing with
them.23 It is possible that the interplay between these two
phenomena contributed to the trend of lower rates of self-
reported behavioral health impairment reported in the
athlete subgroup of our study. Nevertheless, baseline
depression and anxiety are associated with worse pre- and
postoperative hip function (specifically after hip arthros-
copy),9,46 so we still advocate for screening for current or
prior psychological impairment. When appropriate, guiding
affected patients to resources for behavioral health manage-
ment can be incorporated as part of a conservative manage-
ment plan or for preoperative optimization.43
Strengths
Unlike most of the existing PAHD literature, this study
included patients who were evaluated by both operative
and nonoperative sports medicine specialists, and the study
population included patients who both chose and did not
choose to proceed to surgery. The operative and nonopera-
tive specialists at this institution follow a relatively stan-
dard treatment protocol, as described in the Methods
section. However, patients who choose to be evaluated by
operative versus nonoperative specialists may have
TABLE 4
Self-Reported Baseline Health in Athletes Versus Nonathletesa
Athletes (n ¼ 203) Nonathletes (n ¼ 57) MD (95% CI) P Value Athletes/Nonathletes, n
Adult PROMISb
Depression 44.9 ± 8.4 (42.6 to 47.1) 48.2 ± 10.5 (44.7 to 51.7) 3.3 (–0.6 to 7.2) .098 56/37
Anxiety 48.2 ± 9.7 (45.0 to 51.4) 52.6 ± 10.8 (48.2 to 57.0) 4.4 (–0.8 to 9.6) .097 38/25
Pain Interference 59.2 ± 5.2 (57.8 to 60.5) 62.0 ± 6.1 (60.0 to 64.1) 2.9 (0.5 to 5.2) .017 56/37
Physical Function 43.8 ± 5.5 (42.3 to 45.2) 40.7 ± 6.5 (38.6 to 42.9) –3.0 (–5.5 to –0.5) .018 56/37
Mobility 44.4 ± 6.6 (41.3 to 47.4) 41.7 ± 8.3 (36.9 to 46.4) –2.7 (–7.9 to 2.5) .298 20/14
Pediatric PROMISb
Peer Relationships 54.4 ± 9.6 (52.7 to 56.1) 55.1 ± 9.4 (50.3 to 60.0) 0.8 (–4.1 to 5.7) .758 122/17
Pain Interference 55.9 ± 7.5 (54.6 to 57.2) 60.0 ± 6.4 (56.7 to 63.3) 4.1 (0.3 to 7.8) .034 125/17
Mobility 38.1 ± 7.1 (36.8 to 39.3) 36.1 ± 6.8 (32.6 to 39.6) –2.0 (–5.6 to 1.6) .275 125/17
mHHSc 62.8 ± 14.2 (60.1 to 65.5) 58.0 ± 14.0 (53.5 to 62.5) –4.8 (–10.0 to 0.4) .070 107/40
HOOSc
Symptoms 53.9 ± 17.8 (50.5 to 57.4) 50.9 ± 23.1 (43.5 to 58.3) –3.1 (–11.1 to 5.0) .451 107/40
Pain 57.6 ± 18.6 (54.0 to 61.1) 52.8 ± 21.4 (45.9 to 59.6) –4.8 (–11.9 to 2.3) .185 107/40
ADL 70.8 ± 19.0 (67.1 to 74.4) 65.3 ± 22.8 (58.0 to 72.6) –5.4 (–12.8 to 1.9) .146 107/40
Sports 44.2 ± 22.9 (39.8 to 48.6) 38.7 ± 27.2 (30.0 to 47.4) –5.5 (–14.4 to 3.3) .220 106/40
QoL 36.4 ± 19.6 (32.6 to 40.1) 32.5 ± 20.8 (25.9 to 39.1) –3.9 (–11.2 to 3.5) .299 107/40
aVariables are reported as mean ± SD (95% CI). Bolded P values indicate a statistically significant difference between groups. ADL,
Activities of Daily Living; HOOS, Hip disability and Osteoarthritis Outcome Score; MD, mean difference; mHHS, modified Harris Hip Score;
PROM, patient-reported outcome measure; PROMIS, Patient-Reported Outcomes Measurement Information System; QoL, Quality of Life.
bIn total, 97 patients (59 athletes, 38 nonathletes) were 18 years of age and met criteria to complete the Adult PROMIS measures, and
163 patients (144 athletes, 19 nonathletes) were <18 years of age and met criteria to complete the Pediatric PROMIS measures.
cThe mHHS and HOOS PROMs were only completed as standard of care by patients who scheduled surgery with any hip surgeon or if they
were evaluated by the senior hip preservation surgeon.
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inherently different treatment preferences, and the spe-
cialty training backgrounds of specialists may influence the
evaluation and management of patients in ways that have
not yet been thoroughly studied. Therefore, our patient
population likely provides a closer representation of the full
spectrum of patients with PAHD than previous observa-
tional studies that have reported only on patients who have
undergone surgery with nationally and internationally rec-
ognized hip preservation surgeons.
Limitations
Because this study was performed at a single tertiary-care
institution, there is likely still some bias in the population of
patients with PAHD who were evaluated. While some
patients came for their first evaluation of hip pain, others
chose to come or were referred for a second or third opinion
regarding PAHD management. Therefore, our PAHD surgi-
cal rate may still be an overestimate compared with all ado-
lescents and young adults who come to a physician for a first
evaluation of hip pain related to a PAHD. A second limita-
tion is that, because of the departmental workflow, some
PROMs were disproportionately completed by patients who
were initially evaluated by surgeons rather than nonopera-
tive specialists. This was a known limitation from the outset
of the study, but because PROM data in nonsurgical patients
with PAHD are scant in the existing literature, we felt the
analyses were worth pursuing and could still provide valu-
able insight as exploratory findings. Still, our study may
have been underpowered to detect between-group differ-
ences in some of the secondary outcomes. Third, competitive
athlete status was unknown in a small proportion of
TABLE 5
Clinical Characteristics in Athletes Based on Decision to Pursue Hip Surgerya
Surgical Hips (n ¼ 130) Nonsurgical Hips (n ¼ 97) RR (95% CI) MD (95% CI) P Value
Age, y 17.1 ± 2.1 16.8 ± 2.4 — –0.3 (–0.9 to 3.0) .355
Female sex 105 (81) 67 (69) 1.34 (0.98 to 1.83) — .045
Race .700
White 124 (95) 90 (93) 1.03 (0.96 to 1.10) —
Black 3 (2) 5 (5) 0.45 (0.11 to 1.83) —
Asian 2 (2) 1 (1) 1.49 (0.14 to 16.22) —
Hispanic/Latino 1 (1) 1 (1) 0.75 (0.05 to 11.78) —
Grade level .503
Middle school 11 (8) 12 (12) 0.68 (0.32 to 1.48) —
High school 92 (71) 69 (71) 0.99 (0.84 to 1.18) —
College 27 (21) 16 (16) 1.26 (0.72 to 2.20) —
UCLA Activity Scoreb 7.6 ± 2.7 8.4 ± 2.2 — 0.8 (–0.3 to 1.9) .138
BMIc 23.2 ± 3.6 22.7 ± 3.7 — –0.5 (–1.5 to 0.5) .308
Depressiond 7 (5) 4 (4) 1.28 (0.38 to 4.23) — .762
Low back paine 21 (17) 10 (12) 1.42 (0.70 to 2.83) — .334
Hip pain duration <.001
<6 mo 35 (27) 41 (42) 0.64 (0.44 to 0.92) —
6 to 12 mo 34 (26) 18 (19) 1.41 (0.85 to 2.34) —
1 to 3 y 42 (32) 24 (25) 1.31 (0.85 to 2.00) —
3 to 5 y 12 (9) 9 (9) 0.99 (0.44 to 2.27) —
>5 y 7 (5) 5 (5) 1.04 (0.34 to 3.19) —
Hip pathology —
FAI 107 (82) 67 (69) 1.47 (1.09 to 1.99) — .020
Cam 78 (60) 50 (52) 1.16 (0.92 to 1.48) —
Pincer 2 (2) 4 (4) 0.37 (0.07 to 2.00) —
Combined 12 (9) 1 (1) 8.95 (1.18 to 67.70) —
Unknown subtype 15 (12) 12 (12) 0.93 (0.46 to 1.90) —
FAI þ labral tearf 95 (73) 22 (23) 3.22 (2.20 to 4.72) — <.001
Acetabular dysplasia 62 (48) 26 (27) 1.44 (1.16 to 1.79) — .001
Dysplasia þ labral tearf 43 (33) 13 (13) 2.47 (1.41 to 4.33) — .002
Mixed (FAI þ dysplasia) 39 (30) 10 (10) 2.91 (1.53 to 5.54) — .001
(Known) labral tear 109 (84) 39 (40) 2.79 (2.06 to 3.76) — <.001
aContinuous variables are reported as mean ± SD, and categorical variables are reported as n (%). Comparisons between the surgical and
nonsurgical groups are reported as relative risk (RR) for categorical variables and mean difference (MD) for continuous variables. Boldface P
values indicate a statistically significant difference between groups. Dashes indicate not applicable. BMI, body mass index; FAI, femoroace-
tabular impingement; UCLA, University of California, Los Angeles.
bSurgery, n ¼ 83; no surgery, n ¼ 32.
cSurgery, n ¼ 129; no surgery, n ¼ 94.
dSurgery, n ¼ 129; no surgery, n ¼ 96.
eSurgery, n ¼ 124; no surgery, n ¼ 83.
fPatients with FAI, dysplasia, and a known labral tear are represented in both the “FAIþ labral tear” and “Dysplasiaþ labral tear” counts.
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patients, which necessitated their exclusion from the study.
Finally, this study does not elucidate why only the minority
of athletes had bilateral symptoms even though PAHDs are
known to preferentially affect athletes. One possible expla-
nation is that hand dominance and asymmetric daily activ-
ities (such as driving) predispose athletes to move with
asymmetric mechanics even during seemingly symmetric,
reciprocal-type activities such as running. Further dedicated
study is needed in order to understand this phenomenon.
CONCLUSION
In this retrospective study of adolescents and young adults
who were evaluated with hip pain from PAHD, just over
half of both self-reported competitive athletes and nonath-
letes chose surgery within one year, and athletes were no
more likely than nonathletes to proceed to surgery within
that timeframe. Furthermore, an athlete’s progression to
surgery was associated with worse baseline physical
TABLE 6
Self-Reported Baseline Health in Athletes Based on Decision to Pursue Surgerya
Surgical Hips (n ¼ 130) Nonsurgical Hips (n ¼ 97) MD (95% CI) P Value Surgery/No Surgery, n
Adult PROMIS
Depression 44.2 ± 7.6 (41.6 to 46.8) 45.3 ± 9.3 (41.7 to 48.9) 1.1 (–3.1 to 5.3) .608 28/36
Anxiety 48.4 ± 10.1 (44.0 to 52.9) 47.8 ± 9.3 (43.4 to 52.1) –0.7 (–6.7 to 5.4) .827 20/22
Pain Interference 60.3 ± 5.1 (58.6 to 62.0) 58.0 ± 5.0 (56.0 to 59.9) –2.3 (–4.9 to 0.2) .073 36/28
Physical Function 42.9 ± 6.0 (41.0 to 44.8) 44.4 ± 5.5 (42.3 to 46.5) 1.5 (–1.3 to 4.3) .298 36/28
Mobility 44.9 ± 7.4 (40.6 to 49.2) 43.0 ± 4.4 (38.5 to 47.6) –1.9 (–8.7 to 5.0) .572 14/6
Pediatric PROMIS
Peer Relationships 52.8 ± 9.7 (50.6 to 55.0) 56.0 ± 9.1 (53.6 to 58.3) 3.2 (–0.1 to 6.4) .055 77/59
Pain Interference 58.3 ± 5.5 (57.1 to 59.6) 52.9 ± 8.4 (50.7 to 55.1) –5.5 (–7.9 to –3.0) <.001 80/59
Mobility 35.8 ± 4.9 (34.7 to 36.9) 40.6 ± 8.5 (38.4 to 42.8) 4.8 (2.3 to 7.2) <.001 80/59
mHHS 61.9 ± 14.1 (58.8 to 65.0) 66.4 ± 14.2 (61.2 to 71.6) 4.5 (–1.4 to 10.4) .135 82/31
HOOS
Symptoms 51.4 ± 16.4 (47.8 to 55.0) 62.3 ± 18.8 (55.4 to 69.2) 10.8 (3.7 to 18.0) .003 82/31
Pain 54.8 ± 16.7 (51.2 to 58.5) 67.3 ± 21.2 (59.5 to 75.1) 12.5 (4.9 to 20.0) .001 82/31
ADL 68.5 ± 17.9 (64.6 to 72.4) 79.3 ± 19.7 (72.1 to 86.5) 10.8 (3.1 to 18.5) .006 82/31
Sports 40.5 ± 21.1 (35.8 to 45.1) 58.1 ± 24.0 (49.2 to 67.1) 17.7 (8.4 to 26.9) <.001 82/30
QoL 33.7 ± 18.6 (29.6 to 37.8) 45.8 ± 21.6 (37.8 to 53.7) 12.1 (3.9 to 20.2) .004 82/31
aVariables are reported as mean ± SD (95% CI). Boldfaced P values indicate a statistically significant difference between groups. ADL,
Activities of Daily Living; HOOS, Hip disability and Osteoarthritis Outcome Score; MD, mean difference; mHHS, modified Harris Hip Score;
PROMIS, Patient-Reported Outcomes Measurement Information System; QoL, Quality of Life.
TABLE 7
Mean Differences in PROMs Between Patient Subgroups in This Study Compared With Published MCIDsa
Athletes vs Nonathletes Athletes: Surgery vs No Surgery MCID MCID Reference Population
Adult PROMIS
Depression 3.3 (–0.6 to 7.2) 1.1 (–3.1 to 5.3) 2 to 3.1 Chronic MSK pain,26 knee OA28
Anxiety 4.4 (–0.8 to 9.6) –0.7 (–6.7 to 5.4) 2.3 to 3.4 Knee OA28
Pain Interference 2.9 (0.5 to 5.2) –2.3 (–4.9 to 0.2) 2 to 5 Depression,2 back pain,8 knee OA28
Physical Function –3.0 (–5.5 to –0.5) 1.5 (–1.3 to 4.3) 1.9 to 2.2 Knee OA28
Mobility –2.7 (–7.9 to 2.5) –1.9 (–8.7 to 5.0) —
Pediatric PROMIS
Peer Relationships 0.8 (–4.1 to 5.7) 3.2 (–0.1 to 6.4) 2.0 to 3.0 Nephrotic syndrome36,48
Pain Interference 4.1 (0.3 to 7.8) –5.5 (–7.9 to –3.0) 2.0 to 3.0 Nephrotic syndrome36,48
Mobility –2.0 (–5.6 to 1.6) 4.8 (2.3 to 7.2) 2.0 to 3.0 Nephrotic syndrome36,48
mHHS –4.8 (–10.0 to 0.4) 4.5 (–1.4 to 10.4) 8 Hip arthroscopy29
HOOS
Symptoms –3.1 (–11.1 to 5.0) 10.8 (3.7 to 18.0) 9 Hip arthroscopy29
Pain –4.8 (–11.9 to 2.3) 12.5 (4.9 to 20.0) 9 Hip arthroscopy29
ADL –5.4 (–12.8 to 1.9) 10.8 (3.1 to 18.5) 6 Hip arthroscopy29
Sports –5.5 (–14.4 to 3.3) 17.7 (8.4 to 26.9) 10 Hip arthroscopy29
QoL –3.9 (–11.2 to 3.5) 12.1 (3.9 to 20.2) 11 Hip arthroscopy29
aVariables are reported as mean difference (95% CI). Boldfaced mean differences indicate statistical significance. —, no MCID has been
published for adult PROMIS mobility. ADL, Activities of Daily Living; HOOS, Hip disability and Osteoarthritis Outcome Score; MCID,
minimal clinically important difference; mHHS, modified Harris Hip Score; MSK, musculoskeletal; OA, osteoarthritis; PROMIS, Patient-
Reported Outcomes Measurement Information System; QoL, Quality of Life.
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function and hip-related quality of life, but choice for sur-
gery was not associated with worse psychological distress.
These findings provide preliminary evidence that conserva-
tive management may be an acceptable option for some
athletes, especially those with less structural hip pathology
and less severe hip-related baseline physical impairment.
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APPENDIX
Billing codes used in electronic medical record
query for potentially eligible participants.
International Classification of Diseases, Ninth Revision codes:
719.45: Pain in joint, pelvic region, and thigh
719.85: Other specified disorders of joint, pelvic region, and
thigh
754.3: Congenital dislocation of hip
755.63: Other congenital deformity of hip (joint)
International Classification of Diseases, Tenth Revision codes:
M25.551: Pain in right hip
M25.552: Pain in left hip
M25.559: Pain in unspecified hip
M25.851: Other specified joint disorders, right hip
M25.852: Other specified joint disorders, left hip
M25.859: Other specified joint disorders, unspecified hip
M76.892: Other specified enthesopathies of left lower limb,
excluding foot
Q65.2: Congenital dislocation of hip, unspecified
Q65.89: Other specified congenital deformities of hip
Z87.76: Personal history of (corrected) congenital malfor-
mations of integument, limbs, and musculoskeletal
system
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